Zevalin ibritumomab tiuxetan regulatory update

FDA approved a post-approval supplement from Spectrum to remove the requirement for Zevalin indium-111 pre-treatment imaging evaluation prior to treatment with Spectrum's Zevalin ibritumomab tiuxetan....